ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases
– ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases – Programs will leverage ABL Bio’s... Read more.
George Clinical Rebrands as Emerald Clinical Trials
New name reflects company’s growth and vision to help bring certainty and transparency to global clinical trials SINGAPORE, April 7, 2025 /PRNewswire/ —... Read more.
ADP Clear Partners with PIMD to Drive Digital Bunkering Transformation in Singapore
SINGAPORE, April 6, 2025 /PRNewswire/ — Pertamina International Marketing & Distribution Pte. Ltd. (PIMD) has selected ADP Clear to drive its digital bunkering... Read more.
QC Ware Announces 4th Q2B Tokyo Conference Focused on the Roadmap to Quantum Value in Asia and Beyond, Quemix to Co-host and Sponsor
QC Ware hosts the 4th Q2B conference in Tokyo to connect the Asian and global quantum technology landscape and bring together quantum industry experts across computing,... Read more.
TwelveLabs to Bring Its State-of-the-Art Video AI Models to Amazon Bedrock
Latest collaboration enables developers to leverage TwelveLabs’ video understanding capabilities to create new applications with the security, privacy, and... Read more.
NEW STUDY: 73% OF FINTECH STARTUPS FAIL DUE TO REGULATORY CHALLENGES
LOS ANGELES, April 6, 2025 /PRNewswire/ — Nearly three-quarters of financial technology startups fail within their first three years due to preventable regulatory... Read more.
LG EXPANDS MENTAL HEALTH SUPPORT FOR NCAA FINAL FOUR HOST SCHOOLS WITH NAMI PARTNERSHIP
LG continues its commitment to supporting mental health awareness, providing resources and support for students ENGLEWOOD CLIFFS, N.J., April 6, 2025 /PRNewswire/... Read more.
European Patent Office reports Innovation remains robust amid global economic uncertainties: Patent Index 2024
NEW YORK, April 6, 2025 /PRNewswire/ — Companies and inventors from around the world filed 199,264 patent applications at the European Patent Office (EPO)... Read more.
The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine
CHENGDU, China, April 5, 2025 /PRNewswire/ — Keymed Biosciences Inc. (HKEX: 02162) (“Keymed” or the “Company”) today announced that... Read more.
BREAKTHROUGH PRIZE ANNOUNCES 2025 LAUREATES IN LIFE SCIENCES, FUNDAMENTAL PHYSICS, AND MATHEMATICS
“Oscars® of Science” Awards Six $3 Million Prizes GLP-1 Diabetes and Obesity Discovery | Multiple Sclerosis Causes and Treatments | DNA Editing Exploration... Read more.